UArizona Research Shows Drug Can Extend Survival Rates for Heart Failure Patients

Researchers at the University of Arizona College of Medicine – Phoenix have shown for the first time in preclinical studies that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay the progression of congestive heart failure and lengthen survival rates.